These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1515938)

  • 21. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS
    Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
    Boess FG; Riemer C; Bös M; Bentley J; Bourson A; Sleight AJ
    Mol Pharmacol; 1998 Sep; 54(3):577-83. PubMed ID: 9730917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors.
    Clemett DA; Kendall DA; Cockett MI; Marsden CA; Fone KC
    Br J Pharmacol; 1999 May; 127(1):236-42. PubMed ID: 10369478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Grinde E; Gauthier C; Teitler M
    Ann N Y Acad Sci; 1998 Dec; 861():140-5. PubMed ID: 9928251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating mutations of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Egan C; Teitler M
    J Neurochem; 1997 Sep; 69(3):1138-44. PubMed ID: 9282936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain.
    Hulihan-Giblin BA; Park YD; Aulakh CS
    Eur J Pharmacol; 1994 Sep; 263(1-2):213-6. PubMed ID: 7821356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and localization of 5-HT1P receptors in the guinea pig pancreas.
    Kirchgessner AL; Liu MT; Tamir H; Gershon MD
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G553-66. PubMed ID: 1550243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D; Neijt HC
    Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
    Sills MA; Wolfe BB; Frazer A
    Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]Mesulergine, a selective ligand for serotonin-2 receptors.
    Closse A
    Life Sci; 1983 May; 32(21):2485-95. PubMed ID: 6855451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and characterization of the serotonin 5-HT 1D receptor in rat and human brain.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 May; 50(5):1624-31. PubMed ID: 3361315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin (5-HT1c) receptors in pig choroid plexus.
    Yiin KT; Chen CF; Kuo JS; Tsou CT; Wang JJ; Song YM; Lin SH; Tseng LN; Wang YS; Lin WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Mar; 47(3):149-53. PubMed ID: 1848141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.
    Wong DT; Threlkeld PG; Robertson DW
    Neuropsychopharmacology; 1991 Aug; 5(1):43-7. PubMed ID: 1930610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
    Choudhary MS; Craigo S; Roth BL
    Mol Pharmacol; 1992 Oct; 42(4):627-33. PubMed ID: 1435740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 5-hydroxytryptamine1D binding sites in human brain membranes.
    Peroutka SJ; Switzer JA; Hamik A
    Synapse; 1989; 3(1):61-6. PubMed ID: 2521959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
    Westphal RS; Sanders-Bush E
    Mol Pharmacol; 1994 Nov; 46(5):937-42. PubMed ID: 7969083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Necessity of ascorbic acid in the radioligand binding assay for [3H]5-hydroxytryptamine.
    Andresen JW; Shih JC
    Neuropharmacology; 1986 Aug; 25(8):869-75. PubMed ID: 3774116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.